Literature DB >> 3987908

Depressive illness and lung cancer. I. Depression before diagnosis.

J E Hughes.   

Abstract

Twenty-two (16%) of 134 lung cancer patients had symptoms of a major depressive illness at the time they first presented to hospital. This was a higher prevalence than that found in patients with non-malignant chest conditions, or in controls without serious disease. A past history of psychiatric illness, and the presence of metastatic disease, were the most significant correlates of depression. The depressive symptoms had often preceded the physical ones and apparently arisen in reaction to social stress.

Entities:  

Mesh:

Year:  1985        PMID: 3987908

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland.

Authors:  A Montazeri; R Milroy; D Hole; J McEwen; C R Gillis
Journal:  J Epidemiol Community Health       Date:  1998-03       Impact factor: 3.710

2.  Women with lung cancer: impact on quality of life.

Authors:  L Sarna
Journal:  Qual Life Res       Date:  1993-02       Impact factor: 4.147

3.  Psychological distress in survivors of Hodgkin's disease.

Authors:  J Norum; E Wist
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

4.  Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional study.

Authors:  Benchalak Maneeton; Narong Maneeton; Jirayu Reungyos; Suthi Intaprasert; Samornsri Leelarphat; Sumitra Thongprasert
Journal:  Onco Targets Ther       Date:  2014-05-27       Impact factor: 4.147

5.  Self-reported depression among patients with non-small cell lung cancer.

Authors:  Yan Shi; Fen Gu; Li-Li Hou; Yin-Qing Hu
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500

Review 6.  "Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.

Authors:  Nora A Gutierrez Najera; Osbaldo Resendis-Antonio; Humberto Nicolini
Journal:  Front Physiol       Date:  2017-05-09       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.